Western Dermatology Consultants Pc

CLIA Laboratory Citation Details

2
Total Citations
16
Total Deficiencyies
5
Unique D-Tags
CMS Certification Number 32D0941746
Address 10151 Montgomery Blvd Ne Bldg 1 Ste A, Albuquerque, NM, 87111
City Albuquerque
State NM
Zip Code87111
Phone(505) 855-5503

Citation History (2 surveys)

Survey - December 14, 2023

Survey Type: Standard

Survey Event ID: JY2511

Deficiency Tags: D0000 D5217 D5401 D0000 D5217 D5401

Summary:

Summary Statement of Deficiencies D0000 An onsite recertification survey conducted on December 14, 2023, at Western Dermatology Consultants found the laboratory to be in compliance with the CLIA regulations found at 42 CFR, Part 493 Laboratory Requirements, with standard deficiencies cited. D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. This STANDARD is not met as evidenced by: Based on Peer Quality Assurance Review, and staff interview, the laboratory failed to verify the accuracy of non-regulated analytes for 1 of 4 events from 2022 through 2023. Findings Included: 1. Record review of Peer Quality Assurance Review form states a peer review is conducted twice a year. 2. Record review of peer review forms revealed only one peer review was completed for 2022. 3. Laboratory practice manager was asked to provide documentation for second peer review. None were provided. 4. Interview on 12/14/2023 at 10:50 AM with practice manager confirmed the findings. D5401 PROCEDURE MANUAL CFR(s): 493.1251(a) A written procedures manual for all tests, assays, and examinations performed by the laboratory must be available to, and followed by, laboratory personnel. Textbooks may supplement but not replace the laboratory's written procedures for testing or examining specimens. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- This STANDARD is not met as evidenced by: Based on review of Laboratory Compliance Manual "Stain Maintenance", Staining Set-up log, and staff interview, the laboratory failed to follow written procedures for maintenance of acetone, hematoxylin, and eosin for 19 of 27 testing days from September 2023 through December 2023. Finding included: 1. Review of Laboratory Compliance Manual "Stain Maintenance", lists the following maintenance requirement for staining reagents: 1. Acetone - Changed every morning. 2. Hematoxylin - Setup fresh at the new work week and changed as needed during the week. 3. Eosin - Setup fresh at the new work week and changed as needed during the week. 2. Review of Staining Set-up log showed stain maintenance was not followed for acetone for the following days: 1. 9/13/2023 2. 9/14/2023 3. 9/21/2022 4. 9/27 /2022 5. 10/05/2023 6. 10/12/2023 7. 10/26/2023 8. 11/01/2023 9. 11/02/2023 10. 11 /06/2022 11. 11/15/2023 12. 11/16/2023 13. 11/30/2023 14. 12/07/2023 Acetone was topped off and not changed for 14 of 27 testing days. Log stated acetone is changed once a month and not daily. 3. Review of Staining Set-up log showed stain maintenance was not followed for hematoxylin for the following days: 1. 9/20/2023 2. 9/21/2023 3. 10/04/2023 4. 10/05/2023 5. 10/18/2023 6. 10/26/2023 7. 10/30/2023 8. 11/01/2023 9. 11/02/2023 10. 11/06/2023 11. 11/22/2023 12. 12/07/2023 Hematoxylin was topped off and not changed for 12 of 27 testing days. Log stated Hematoxylin is changed twice a month and not weekly. 4. Review of Staining Set-up log showed stain maintenance was not followed for eosin for the following days: 1. 9 /20/2023 2. 9/21/2023 3. 10/04/2023 4. 10/05/2023 5. 10/18/2023 6. 10/26/2023 7. 10 /30/2023 8. 11/01/2023 9. 11/02/2023 10. 11/06/2023 11. 11/22/2023 12. 12/07/2023 Eosin was topped off and not changed for 12 of 27 testing days. Log stated Eosin is changed twice a month and not weekly. 5. Interview on 12/14/2023 at 10:20 AM with practice manager confirmed the findings. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - April 11, 2022

Survey Type: Standard

Survey Event ID: YI9011

Deficiency Tags: D0000 D3013 D5217 D5401 D5413 D0000 D3013 D5217 D5401 D5413

Summary:

Summary Statement of Deficiencies D0000 Based upon the onsite recertification survey conducted on 04/11/2022, this facility was found NOT to be in compliance with the CLIA regulations found at 42 CFR for the specialties/subspecialties in which it was surveyed. D3013 FACILITIES CFR(s): 493.1101(e) Records and, as applicable, slides, blocks, and tissues must be maintained and stored under conditions that ensure proper preservation. This STANDARD is not met as evidenced by: Based on observation and interview with the Practice Manager, the laboratory failed to monitor, document, and define the room temperature range to ensure long-term preservation of the histopathology slides. Findings included; 1. Tour of the laboratory on 04-11-22 at 2:16 pm revealed the laboratory failed to monitor and document the temperature and the humidity of the room in which histopathology slides were stored. 2. During an interview with the Practice Manager and the Front Office Manager on 04- 11-22 at 2:30 pm, they confirmed that they did not have a thermometer in the laboratory and that they had not been monitoring and documenting the temperature. D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. This STANDARD is not met as evidenced by: Based on the review of the Peer Quality Assurance documentation and interview with Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- the Practice Manager, the laboratory failed to define the acceptability for verifying accuracy of Mohs examinations twice annually in a written procedure. 1. Review of the Form titled "Peer Quality Assurance Review" for 2019, 2020, and 2021, revealed that the forms lacked the raw data, showing verification of key components of comparison regarding the gross examination and the test reporting. 2. During an interview with the Laboratory Practice Manager and the front Office Manager on 04- 11-22 at 3:30 pm, the surveyor asked for the raw data showing the key components for the comparison of the MOHs cases listed on the review forms and found it had not been documented. This verified the above findings. D5401 PROCEDURE MANUAL CFR(s): 493.1251(a) A written procedures manual for all tests, assays, and examinations performed by the laboratory must be available to, and followed by, laboratory personnel. Textbooks may supplement but not replace the laboratory's written procedures for testing or examining specimens. This STANDARD is not met as evidenced by: Based on the review of records and interview with the Practice Manager, the laboratory failed to ensure a written procedure manual for Mohs examinations was available to personnel. Findings are: 1. Review of the records revealed there were no written policies and procedures for Mohs examinations performed in the laboratory. 2. During an interview with the Practice Manager, on 04-11-22 at 3:05 pm she stated, "I cannot locate the policies because they might have been archived." D5413 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(b) The laboratory must define criteria for those conditions that are essential for proper storage of reagents and specimens, accurate and reliable test system operation, and test result reporting. The criteria must be consistent with the manufacturer's instructions, if provided. These conditions must be monitored and documented and, if applicable, include the following: (1) Water quality. (2) Temperature. (3) Humidity. (4) Protection of equipment and instruments from fluctuations and interruptions in electrical current that adversely affect patient test results and test reports. This STANDARD is not met as evidenced by: Based on observation, and interview with staff, the laboratory failed to monitor, document and define the temperature and humidity of the room in which reagents and equipment were stored for 2019, 2020, and 2021. Findings included; 1. Tour of the laboratory on 04-11-22 at 2:16 pm revealed the laboratory failed to monitor and document the temperature and the humidity of the room in which reagents and equipment were stored. The following reagents and equipment had Manufacturer's temperature storage requirements and were stored in the laboratory; A. Eosin-Y Alcoholic, 2-1 gal bottles, Lot #112277. Expiration date = 10/2023 - Manufacturer's temperature storage requirement listed on bottle was 15C-30C. B. Hematoxylin Solution, 2-1 gal bottles, Lot #112277. Expiration date = 10/2023 - Manufacturer's temperature storage requirement listed on bottle was 15C-30C. C. The Avantik QS12 Cryostat had the following Manufacturer's requirements; a. Temperature (Recommended Operation) requirement of +15C to +30C (+59F to + 86F). "Note: -- 2 of 3 -- Performance may deteriorate when operated outside this range". b. Temperature (Transport and Storage) requirement of -20C to +50C (-4F to 122F). c. Relative Humidity - "Max. 60% RH up to 30C". 2. During an interview with the Practice Manager and the Front Office Manager on 04-11-22 at 2:30 pm, they confirmed that they did not have a thermometer in the laboratory and that they had not been monitoring and documenting the temperature. -- 3 of 3 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access